Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRC | P12931 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | DPP4 | P27487 | 2/20 | 0.34 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3472688 | 0.86 | ALDH1A1 (0.42) | SRCALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL4458309 | 0.86 | ALDH1A1 (0.42) | SRCALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL17169185 | 0.85 | SRC (0.50) | SRCALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL28611135 | 0.85 | SRC (0.44) | SRCALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL29273766 | 0.85 | SRC (0.44) | SRCALDH1A1RAB9AMEN1KMT2A | |
| Triphenyl Phosphate SCHEMBL28244551 | 0.84 | SRC (0.50) | SRCALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL5859474 | 0.83 | PKM (0.36) | SRCALDH1A1RAB9AMEN1KMT2A | |
| SCHEMBL343723 | 0.79 | SRC (0.59) | SRCALDH1A1POLBTDP1L3MBTL1 | |
| SCHEMBL22171417 | 0.78 | CYP3A4 (0.51) | ALDH1A1RAB9AMEN1KMT2ANPSR1 | |
| SCHEMBL4462734 | 0.78 | SRC (0.47) | SRCMEN1KMT2ALMNADPP7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7019056-B2 | Flame retardants which contain phosphorus, and flame-retardant thermoplastic molding compositions | BAYER AKTIENGESELLSCHAFT (DE) | 2006-03-28 | — | — | US | disclosed |
| US-20020137821-A1 | Flame retardants which contain phosphorus, and flame-retardant thermoplastic molding compositions | COVESTRO DEUTSCHLAND AG (DE) | 2002-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020137821-A1 | Flame retardants which contain phosphorus, and flame-retardant thermoplastic molding compositions | FBP1, PFN1, PFKFB1 | SRC 3938/4885ALDH1A1 672/4885RAB9A 3777/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.